Cytori Reports Q1 2019 Business and Financial Results

NEXT STORY
Biogen’s SPINRAZA® (nusinersen) Receives Positive Recommendation from NICE for Funding in the United Kingdom for the Treatment of Infants, Children and Adults with Spinal Muscular Atrophy
PREV STORY
Turning Point Therapeutics’ CEO to Present at UBS Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Agios Presents Mitapivat Long-term Extension Data Demonstrating Durability of Hemoglobin Response and Transfusion Burden Reduction in Adults with Pyruvate Kinase (PK) Deficiency at 63rd ASH Annual Meeting and Exposition

author_avatar
NASDAQ Market News

Innate Pharma présente des données préliminaires de l’essai TELLOMAK montrant une réponse clinique avec lacutamab dans le mycosis fungoides

author_avatar
NASDAQ Market News

The continuing medical education market is expected to grow at a CAGR of approximately 7% during 2021-2026

author_avatar
NASDAQ Market News